AC

Aisling Capital Portfolio holdings

AUM $45.3M
This Quarter Return
+16.55%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$516M
AUM Growth
+$516M
Cap. Flow
+$152M
Cap. Flow %
29.42%
Top 10 Hldgs %
81.88%
Holding
18
New
5
Increased
–
Reduced
1
Closed
–

Top Buys

1
TTOO
T2 Biosystems, Inc
TTOO
$45.6M
2
LOXO
Loxo Oncology, Inc
LOXO
$45.3M
3
CTLT
CATALENT, INC.
CTLT
$44.1M
4
ROKA
Sorrento Tech, Inc. Common Stock
ROKA
$11.3M
5
XENT
Intersect ENT, Inc
XENT
$5.43M

Top Sells

1
MEIP icon
MEI Pharma
MEIP
$56.6K

Sector Composition

1 Healthcare 72.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZLTQ
1
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$58.8M 11.4% 2,597,742 – –
ESPR icon
2
Esperion Therapeutics
ESPR
$448M
$50.3M 9.75% 2,054,594 – –
TTOO
3
DELISTED
T2 Biosystems, Inc
TTOO
$45.7M 8.85% +2,523,300 New +$45.6M
LOXO
4
DELISTED
Loxo Oncology, Inc
LOXO
$45.3M 8.79% +3,452,493 New +$45.3M
CTLT
5
DELISTED
CATALENT, INC.
CTLT
$44.1M 8.55% +1,761,225 New +$44.1M
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
$42.1M 8.16% 1,522,943 – –
ARAV
7
DELISTED
Aravive, Inc. Common Stock
ARAV
$37.9M 7.35% 1,994,568 – –
ASXC
8
DELISTED
Asensus Surgical, Inc.
ASXC
$36.3M 7.05% 8,335,819 – –
CEMP
9
DELISTED
Cempra, Inc.
CEMP
$36.1M 7% 3,293,060 – –
DRTX
10
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$25.7M 4.99% 2,030,175 – –
AMBI
11
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
$25.4M 4.93% 1,650,156 – –
AGRX
12
DELISTED
Agile Therapeutics, Inc
AGRX
$15.9M 3.07% 2,171,831 – –
PTX
13
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$15.4M 2.99% 2,010,000 – –
ROKA
14
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$11.3M 2.19% +1,122,417 New +$11.3M
SRNE
15
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$7.97M 1.55% 1,763,500 – –
EVAR
16
DELISTED
Lombard Medical, Inc.
EVAR
$6.82M 1.32% 886,363 – –
XENT
17
DELISTED
Intersect ENT, Inc
XENT
$5.43M 1.05% +350,000 New +$5.43M
MEIP icon
18
MEI Pharma
MEIP
$160M
$5.26M 1.02% 761,800 -8,200 -1% -$56.6K